Fortis Healthcare appoints Ashutosh Raghuvanshi as MD and CEO; to help firm achieve profitability, growth objectives
At Fortis, Raghuvanshi will be responsible for the day-to-day management decisions of the company and for implementing its long- and short-term plans, the filing said.
Fortis saga: Believe in Indian judicial process, hopeful of a positive outcome in SC, says IHH MD & CEO Tan See Leng
IHH and Fortis are not involved in the dispute between Daiichi and the Singh brothers and are hopeful of a positive outcome on the status quo on the open offer in the next hearing in the Supreme Court scheduled on 14 March, a top Malaysian firm official said on Friday
In February last year, Fortis had announced that it has entered into definitive agreements with RHT to acquire entire portfolio of assets of the Singapore-listed entity for an enterprise value of Rs 4,650 crore.
A letter of the offer to Fortis shareholders was submitted to the bourses
Former Fortis and Ranbaxy promoters Malvinder Singh and Shivinder Mohan reportedly came to blows in the latest turn to their ongoing feud.
Sebi directs Singh brothers, 8 other entities to repay over Rs 403 cr with interest to Fortis Healthcare
In a 21-page interim order, Sebi said that prima facie the role of FHL and Fortis Hospitals Ltd (FHsL) in the alleged diversion of funds through conduit entities has been established.
Fortis Healthcare: Shivinder Mohan Singh to withdraw NCLT petition against brother Malvinder after mother intervenes
Shivinder Singh had filed a lawsuit in the NCLT against brother Malvinder saying alleging "oppression and mismanagement" at their joint businesses.
A two-member bench headed by NCLT President Justice M M Kumar issued notices to Malvinder Singh, Sunil Godhwani and others after Shivinder Singh's petition over alleged "oppression and mismanagement" of RHC Holdings.
The court’s order came after it was informed by the counsel for Malvinder, who was present in the court, that his 45 lakh equity shares in Religare Healthcare Pvt Ltd were sold in Singapore in April.
Fortis Healthcare case: Shivinder Singh says elder brother Malvinder forged wife's signature, led firm into debt trap
Shivinder Singh, the younger of the Singh siblings, who were synonymous with each other for decades, sued Malvinder for "oppression and mismanagement" of their companies.
Fortis Healthcare: Singh brothers say Sunil Godhwani 'orchestrated transactions' that left Group in debt
Godhwani had stepped down as the chairman and managing director in 29 July, 2016. Subsequently, he assumed charge of the CEO in Religare Enterprises.
Fortis stake sale: Cash-strapped healthcare major shortlists four prospective buyers; appoints new chairman
Earlier this week, Fortis Healthcare initiated a fresh time-bound bidding process for its sale after terminating the offer made by the Munjal-Burman combine.
Fortis stake sale: Board outlines fresh bidding process, bidders given 10 days for financial, legal due diligence
The bids should also provide a plan for funding Fortis’s acquisition of RHT Health Trust’s Indian assets, agreed in November, and options to private equity investors to exit Fortis’s unit SRL Ltd.
Malaysian firm IHH Healthcare Berhard on Friday extended the acceptance period for its enhanced revised proposal for acquiring Fortis to 30 June
Fortis stake sale: Independent director quits ahead of board meet tomorrow citing 'personal reasons'
The crucial stakeholders meeting to be held on 22 May to decide the fate of four independent directors -- Brian Tempest, Harpal Singh, Sabina Vaisoha and Gen Shergill.
IHH Healthcare had increased its offer to directly invest in Fortis Healthcare at Rs 175 per share on 1 May. It had initially made a non-binding offer to invest in Fortis at Rs 160 per share.
Fortis stake sale: Latest bid 'more risky', says Manipal CEO Ranjan Pai as hospital mired in regulatory investigation
India’s privately held Manipal Hospitals had to take a “more risky” approach in its latest bid for domestic rival Fortis Healthcare to see off rival suitors, said Manipal’s Chief Executive Ranjan Pai.
Fortis stake sale: Manipal-TPG revises offer again, values it at Rs 8,358 cr; proposes to infuse Rs 2,100 crore upfront
Manipal Health also offered to subscribe to the equity shares of Fortis by way of preferential allotment for Rs 2,100 crore at a price per equity share of Rs 160.
1 May is the deadline for binding offers for Fortis, which will be evaluated by an expert advisory panel. The board is set to meet on 10 May.
Fortis stake sale: Race to acquire healthcare major heats up with Malaysia's IHH, Munjals and Burmans hiking offers
The deadline set by Fortis' board to review all binding offers received ended at 12 noon today.